|Bid||77.03 x 800|
|Ask||87.00 x 800|
|Day's Range||84.94 - 86.17|
|52 Week Range||63.37 - 87.72|
|PE Ratio (TTM)||67.59|
|Earnings Date||Oct 31, 2018 - Nov 5, 2018|
|Forward Dividend & Yield||0.28 (0.33%)|
|1y Target Est||87.25|
NEW YORK, Aug. 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cognex ...
In his second "Executive Decision" segment of Mad Money last night our own Jim Cramer sat down with Robert Friel, the chairman, CEO and president of PerkinElmer, Inc. In this daily bar chart of PKI, below, we can see that last week prices soared and broke out above the January high. The daily On-Balance-Volume (OBV) line has been rising throughout all of July telling us that traders turned more aggressive on the buy side.
The Nasdaq led gains in stocks today, and Apple reached a new all-time high. The stock is extended past a pair of recent new buy points.
Apple leads five top stocks to watch that are in or near buy range and showing relative strength. CSX, Ross Stores, Zoetis and PerkinElmer are also triggering a bullish technical signal.
The canny investor should always be looking for top stocks with accelerating sales growth. This key bullish trait is shared by Apple stock, PerkinElmer, SVB Financial and Square.
Solid performance by PerkinElmer's (PKI) DAS and Diagnostics arms is a key positive in Q2. The company saw strength across all major geographies in Asia, Americas, Europe and the BRIC nations.
PerkinElmer (PKI) delivered earnings and revenue surprises of 5.81% and 1.38%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The Waltham, Massachusetts-based company said it had profit of 57 cents per share. Earnings, adjusted for one-time gains and costs, were 91 cents per share. The results surpassed Wall Street expectations. ...
WALTHAM, Mass.-- -- GAAP revenue growth of 29% to $703.4 million; Core Organic revenue growth of 10% GAAP earnings per share from continuing operations of $0.58; Adjusted earnings per share of $0.91, an increase of 36% GAAP operating income margin of 12.5%; Adjusted operating income margin from continuing operations of 19.7%, an increase of 180 basis points Raises FY18 Guidance PerkinElmer, Inc. , ...
PerkinElmer (PKI) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
The Board of Directors of PerkinElmer, Inc. , declared a regular quarterly dividend of $0.07 per share of common stock on July 23, 2018. This dividend is payable on November 9, 2018 to all shareholders of record at the close of business on October 19, 2018.
athenahealth's (ATHN) core Business Services unit is likely to drive growth in Q2; the company's focus on cloud-based services is encouraging.
Strong performance in the Diagnostics Segment is likely to drive PerkinElmer's (PKI) Q2 results. The segment fortifies the company's market position in terms of exclusiveness of services.
PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced that on Wednesday, August 1, 2018, after market close, the Company will release second quarter 2018 results.
Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on June 20. Index (PMI) data, output in the Consumer Goods sector is rising.
Stock Research Monitor: PKI, PRAH, and PRPO LONDON, UK / ACCESSWIRE / June 26, 2018/ If you want a free Stock Review on DGX sign up now at www.wallstequities.com/registration . On Monday, benchmark US ...
PerkinElmer Inc (NYSE:PKI), a life sciences company based in United States, saw significant share price volatility over the past couple of months on the NYSE, rising to the highs ofRead More...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Goods sector is rising.
PerkinElmer, Inc. (PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 38th annual Goldman Sachs Global Healthcare Conference on Wednesday, June 13, 2018 at 2:00 p.m. PT at the Terranea Resort in Rancho Palos Verdes, Calif. Robert F. Friel, PerkinElmer’s chairman and chief executive officer, will provide an overview of the Company and its strategic priorities. A live audio webcast of the presentation will also be available on the Investors section of the Company’s website at www.perkinelmer.com.
Ahead of today's trading session, WallStEquities.com scans four Medical Laboratories and Research stocks, particularly: PerkinElmer Inc. (NYSE: PKI), Precipio Inc. (NASDAQ: PRPO), Syneos Health Inc. (NASDAQ: SYNH), and Thermo Fisher Scientific Inc. (NYSE: TMO). Medical laboratories are independent, commercial enterprises that provide information to the health care professionals about the severity, onset, and reason of patients' physical ailments.